Clinical Trial Confidentiality Agreement Template for Saudi Arabia

1. Third Party Disclosure: Additional provisions for cases where third party contractors or consultants need access to confidential information

2. International Data Transfer: Required when confidential information will be transferred outside Saudi Arabia

3. Publication Rights: Provisions regarding publication of trial results, used when academic institutions are involved

4. Intellectual Property Rights: Additional provisions when the confidential information includes patentable inventions or innovations

5. Emergency Disclosure Provisions: Special provisions for emergency situations requiring immediate disclosure of information

6. Clinical Trial Subject Privacy: Additional provisions specifically addressing trial subject data privacy when personal health information is involved

7. Shariah Compliance Declaration: Specific section confirming compliance with Islamic law principles, used when required by parties

1. Schedule 1: Description of Clinical Trial: Detailed description of the clinical trial including protocol number and basic design

2. Schedule 2: Authorized Representatives: List of authorized representatives from each party who may receive confidential information

3. Schedule 3: Security Protocols: Specific security measures and protocols for handling confidential information

4. Schedule 4: Data Processing Requirements: Detailed requirements for data processing in compliance with PDPL

5. Appendix A: Form of Confidentiality Undertaking: Template for confidentiality undertaking to be signed by individual representatives

6. Appendix B: Data Return/Destruction Certificate: Template certificate confirming return or destruction of confidential information